Annotation Detail for CCDC94
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D013629 |
Tamoxifen |
Tamoxifen results in increased expression of CCDC94 mRNA | increases expression | 17555576
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.96 | 14745880 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.16 | 19142967 21138602 20135344 20065188 19289846 19487384 18984771 17049068 17242785 19066611 18351453 17440819 16202921 19059307 18855134 16818667 20005174 19244106 18425577 19103187 20390343 16273361 19200415 16873071 18629630 19410462 20544844 18821012 21152245 18997820 19084267 17893378 11161223 18815881 19011961 19288272 19115204 19189210 15565566 17261762 20859285 15668708 19221464 19155303 19189212 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
5.41 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.86 | 16924424 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
4.19 | 17572228 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
5.27 | 19031437 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
4.00 | 19279558 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
4.32 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.37 | 17893378 16202921 20544844 19155303 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
3.79 | 14986274 19224547 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.52 | 16709447 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
5.62 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
5.27 | 19069698 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.59 | 19457130 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.53 | 18625569 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.53 | 15342952 17567588 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
1.75 | 18564211 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
2.37 | 16684651 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
1.75 | 18625569 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.85 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.94 | 14580682 19196723 11731420 16827153 19196722 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.96 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.93 | 19393235 12393984 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
5.27 | 15990972 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.71 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.64 | 19410462 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
5.41 | 19196722 19189210 19200415 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.07 | 15067354 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
5.71 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
5.13 | 19457130 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.51 | 16712894 8653321 17572228 |
Related Pathway Information